Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States-Reference-Cited by-同舟云学术

Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States

Published:2016-05-24 Issue:8 Volume:91 Page:770-775
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Nabhan Chadi¹,Zhou Xiaolei²,Day Bann-Mo³,Dawson Keith³,Zelenetz Andrew D.⁴,Friedberg Jonathan W.⁵,Cerhan James R.⁶,Link Brian K.⁷,Flowers Christopher R.⁸

Affiliation:

1. Section of Hematology and Oncology; Department of Medicine; the University of Chicago

2. Biometrics, RTI Health Solutions; North Carolina

3. Medical Affairs, Genentech, Inc; California

4. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York

5. James P Wilmot Cancer Center; the University of Rochester; New York

6. Health Sciences Research; Mayo Clinic; New York

7. Department of Medicine; the University of Iowa; Iowa

8. Winship Cancer Institute; Emory University; Georgia

Funder

Genentech Inc., South San Francisco, CA/F

Hoffmann-La Roche Ltd, Basel, Switzerland

Publisher

Wiley

Subject

Hematology

Reference20 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States;Nabhan;Br J Haematol,2015

3. Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: Report from the National LymphoCare Study;Nabhan;Cancer,2012

4. Prognosis of follicular lymphoma: A predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi;Federico;Blood,2000

5. Follicular lymphoma international prognostic index;Solal-Celigny;Blood,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes;American Journal of Hematology;2024-01-13

2. Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis;American Journal of Hematology;2023-02-24

3. Sex differences in lymphoma incidence and mortality by subtype: A population‐based study;American Journal of Hematology;2022-10-10

4. Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy;Acta Oncologica;2022-04-22

5. A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib;Advances in Therapy;2022-02-14